Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0RD9V
|
|||
Drug Name |
Quinolinyl pyrazinyl urea derivative 2
|
|||
Synonyms |
PMID27828716-Compound-3
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H10F3N5O
|
|||
Canonical SMILES |
C1=CC2=NC=CC(=C2C=C1C(F)(F)F)NC(=O)NC3=NC=CN=C3
|
|||
InChI |
1S/C15H10F3N5O/c16-15(17,18)9-1-2-11-10(7-9)12(3-4-20-11)22-14(24)23-13-8-19-5-6-21-13/h1-8H,(H2,20,21,22,23,24)
|
|||
InChIKey |
GHAZVJQMLWOQLP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glycogen synthase kinase-3 alpha (GSK-3A) | Target Info | Inhibitor | [1] |
Target's Patent Info | Glycogen synthase kinase-3 alpha (GSK-3A) | Target's Patent Info | [1] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
Insulin/IGF pathway-protein kinase B signaling cascade | ||||
PDGF signaling pathway | ||||
Ras Pathway | ||||
Pathway Interaction Database | Degradation of beta catenin | |||
Canonical Wnt signaling pathway | ||||
FOXM1 transcription factor network | ||||
Class I PI3K signaling events mediated by Akt | ||||
Reactome | AKT phosphorylates targets in the cytosol | |||
XBP1(S) activates chaperone genes | ||||
Constitutive Signaling by AKT1 E17K in Cancer |
References | Top | |||
---|---|---|---|---|
REF 1 | Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015).Expert Opin Ther Pat. 2017 Jun;27(6):657-666. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.